For a long time, cancer has been considered a disease primarily linked to aging. Today, however, epidemiological data tell a more complex story. By the end of 2025, a surprising picture emerges: while overall cancer mortality decreases thanks to targeted therapies, the incidence of tumors among adults under 50—known as early-onset cancers—is rising. An analysis reported by the New York Times and supported by studies published in Annals of Internal Medicineindicates that six t
